- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/38 - One oxygen atom attached in position 2
Patent holdings for IPC class C07D 263/38
Total number of patents in this class: 64
10-year publication summary
|
5
|
5
|
5
|
7
|
4
|
5
|
5
|
3
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 428 |
19 |
| Novartis AG | 10376 |
3 |
| Takeda Pharmaceutical Company Limited | 2720 |
3 |
| Denali Therapeutics Inc. | 258 |
3 |
| Vectus Biosystems Limited | 28 |
3 |
| BASF SE | 21127 |
2 |
| CHDI Foundation, Inc. | 105 |
2 |
| Symrise AG | 1804 |
2 |
| Theravance, Inc. | 63 |
2 |
| The Regents of the University of California | 20473 |
1 |
| Syngenta Participations AG | 1595 |
1 |
| Sabic Innovative Plastics IP B.V. | 657 |
1 |
| AMOREPACIFIC Corporation | 2881 |
1 |
| Auspex Pharmaceuticals, Inc. | 141 |
1 |
| Chicago Discovery Solutions, LLC | 2 |
1 |
| Moehs Iberica, S.L. | 32 |
1 |
| Provincial Health Services Authority | 188 |
1 |
| The Scripps Research Institute | 1344 |
1 |
| Soochow University | 1767 |
1 |
| Takasago International Corporation | 404 |
1 |
| Other owners | 14 |